| Date Filed | Type | Description |
| 02/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2022 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Sold 11,228 shares
@ $2.4188, valued at
$27.2k
Exercised 11,228 options to buy
@ $0.69, valued at
$7.7k
|
|
| 01/05/2022 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 75,000 shares
@ $0 |
|
| 10/05/2021 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on Xeris Biopharma Holdings, Inc.|
Txns:
| Granted 384,780 shares
@ $0
Granted 110,000 shares
@ $0
Granted 11,228 options to buy
@ $0.69, valued at
$7.7k
Granted 28,072 options to buy
@ $1.55, valued at
$43.5k
Granted 11,266 options to buy
@ $1.55, valued at
$17.5k
Granted 14,036 options to buy
@ $5.93, valued at
$83.2k
Granted 25,000 options to buy
@ $13.88, valued at
$347k
Granted 25,000 options to buy
@ $3.94, valued at
$98.5k
|
|
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
3
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 3 on Xeris Biopharma Holdings, Inc. |
| 04/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Gifted 10,000 shares
@ $0 |
|
| 08/17/2020 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Granted 25,000 options to buy
@ $4.19, valued at
$104.8k
|
|
| 03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $5.4992, valued at
$55k
|
|
| 11/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/16/2019 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Sold 7,700 shares
@ $17.2025, valued at
$132.5k
Sold 9,962 shares
@ $12.037, valued at
$119.9k
Sold 38 shares
@ $12.7, valued at
$482.6
Sold 10,000 shares
@ $7.9746, valued at
$79.7k
|
|
| 04/12/2019 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Sold 10,000 shares
@ $9.5649, valued at
$95.6k
|
|
| 02/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2019 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Sold 2,300 shares
@ $0 |
|
| 01/02/2019 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Sold 15,720 shares
@ $15.823, valued at
$248.7k
Exercised 15,720 options to buy
@ $1.19, valued at
$18.7k
|
|
| 06/27/2018 |
4
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 4 on XERIS PHARMACEUTICALS INC|
Txns:
| Converted 30,232 shares
@ $0
Converted 7,130 shares
@ $0
Converted 53,849 preferred shares
@ $0
Converted 12,701 preferred shares
@ $0 |
|
| 06/20/2018 |
3
| PRESTRELSKI STEVEN (Chief Scientific Officer) has filed a Form 3 on XERIS PHARMACEUTICALS INC |